Nanobiotix SA (NBTX) Earnings Date & Reports

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NBTX is expected to report earnings to fall 63.26% to -40 cents per share on September 04

Nanobiotix SA NBTX Stock Earnings Reports

Q2'25

Est.

$-0.40

Q4'24

Missed

by $0.36

Q2'24

Est.

$-0.51

Q4'23

Beat

by $0.75

The last earnings report on April 02 showed earnings per share of -109 cents, missing the estimate of -73 cents. With 2.64K shares outstanding, the current market capitalization sits at 160.85M.

View a ticker or compare two or three

Compare

NBTX